Lung cancer therapeutics that target signaling pathways: an update
Authors:
- 1 October 2010
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Respiratory Medicine
- Vol. 4 (5) , 631-645
Abstract
(2010). Lung cancer therapeutics that target signaling pathways: an update. Expert Review of Respiratory Medicine: Vol. 4, No. 5, pp. 631-645.Keywords
This publication has 144 references indexed in Scilit:
- Targeting HSP90 for cancer therapyBritish Journal of Cancer, 2009
- IGF2: Epigenetic regulation and role in development and diseaseCytokine & Growth Factor Reviews, 2008
- TRAIL receptor-targeted therapeutics: Resistance mechanisms and strategies to avoid themDrug Resistance Updates, 2008
- Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancerNature Reviews Drug Discovery, 2007
- The Epigenomics of CancerCell, 2007
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 2004
- The language of covalent histone modificationsNature, 2000
- The Hallmarks of CancerCell, 2000
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997
- Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endotheliumNature, 1995